If you have been reading about fatty diacid and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-07-25. Numbers and descriptions here follow the published literature rather than marketing material.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Approximate composition of the free peptide |
| Molecular weight | Approximately 4813 Da | Calculated for the free base |
| Structural class | Synthetic linear peptide | 39 residues with modified backbone |
| Solubility | Soluble in water and polar solvents | Behavior of the lyophilized solid |
| Typical storage temperature | -20 degrees Celsius or below | Solid form, protected from light |
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
Stability depends strongly on physical form. The dry powder is generally regarded as stable for extended periods when held at or below minus twenty degrees Celsius in a sealed, desiccated container. In solution, degradation pathways include deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation. Reaction rates for these pathways rise with temperature. Repeated freezing and thawing of solutions promotes aggregation, and light exposure can accelerate some oxidative changes. Buffer composition and pH influence which pathway dominates at a given temperature.
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
Transition metal amino acid complexes are a large family of coordination complexes containing the conjugate bases of the amino acids, the 2-aminocarboxylates. Amino acids are prevalent in nature, and all of them function as ligands toward the transition metals. Not emphasized in this article are complexes of amino acid amides (including peptide) and ester derivatives of amino acids.
Although the modern periodic table is standard today, the placement of the period 1 elements hydrogen and helium remains an open issue under discussion, and some variation can be found. Following their respective s1 and s2 electron configurations, hydrogen would be placed in group 1, and helium would be placed in group 2. The group 1 placement of hydrogen is common, but helium is almost always placed in group 18 with the other noble gases. The debate has to do with conflicting understandings of the extent to which chemical or electronic properties should decide periodic table placement. Like the group 1 metals, hydrogen has one electron in its outermost shell and typically loses its only electron in chemical reactions. Hydrogen has some metal-like chemical properties, being able to displace some metals from their salts. But it forms a diatomic nonmetallic gas at standard conditions, unlike the alkali metals which are reactive solid metals. This and hydrogen's formation of hydrides, in which it gains an electron, brings it close to the properties of the halogens which do the same (though it is rarer for hydrogen to form H− than H+). Moreover, the lightest two halogens (fluorine and chlorine) are gaseous like hydrogen at standard conditions. Some properties of hydrogen are not a good fit for either group: hydrogen is neither highly oxidizing nor highly reducing and is not reactive with water. Hydrogen thus has properties corresponding to both those of the alkali metals and the halogens, but matches neither group perfectly, and is thus difficult to place by its chemistry.
Gemini 4 (officially Gemini IV) was the second crewed spaceflight in NASA's Project Gemini, occurring in June 1965. It was the tenth crewed American spaceflight (including two X-15 flights at altitudes exceeding 100 kilometers (62 mi; 54 nmi)). Astronauts James McDivitt and Ed White orbited the Earth 66 times in four days, making it the first US flight to approach the five-day flight of the Soviet Vostok 5. The highlight of the mission was the first space walk by an American, during which White floated free outside the spacecraft, tethered to it, for approximately 23 minutes. The flight also included the first attempt to make a space rendezvous as McDivitt attempted to maneuver his craft close to the Titan II upper stage which launched it into orbit, but this was not successful. The flight was the first American flight to perform many scientific experiments in space, including use of a sextant to investigate the use of celestial navigation for lunar flight in the Apollo program.
Sources: en.wikipedia.org
===== Pharmacodynamics ===== The melanocortin receptor agonist proposes to activate multiple receptor subtypes nonselectively, with the highest affinity with MC1R, then MC4R, MC3R, MC5R, and MC2R receptors. As MC4R receptors are present on neurons in the central nervous system, a function in modulating brain pathways is suggested, albeit a precise mechanism remains unknown.
=== In the West Pacific === Native aluminium has been reported also in cold seeps in the northeastern continental slope of the South China Sea and Chen et al. (2011) have proposed a theory of its origin as resulting by reduction from tetrahydroxoaluminate Al(OH)4− to metallic aluminium by bacteria.
Because the city had flourished in the heyday of the auto industry, local politicians made periodic attempts to stimulate a revival of the auto industry in the city. For example, in the 1980s the cities of Detroit and Hamtramck used the power of eminent domain to level part of what had been Poletown to make a parking lot for a new automobile factory. On that site, a new, low-rise suburban type Cadillac plant was built, with substantial government subsidies. The new Detroit/Hamtramck Assembly employs 1,600 workers. In the 1990s, the city subsidized the building of a new Chrysler plant on the city's east side, Jefferson North Assembly, which employs 4,600 people. In 2009 Chrysler filed a Chapter 11 bankruptcy case, and survives in a partnership with Fiat of Italy, while GM filed for Chapter 11 bankruptcy on June 1, 2009, and survives as a much smaller company—smaller now than Japan's Toyota Motor Corporation. A little over two years after these major blows to the U.S. auto industry, the city itself went into Chapter 9 bankruptcy after years of mismanagement by local leaders.
==== The "ethnic nose" ==== The open rhinoplasty approach affords the plastic surgeon advantages of ease in securing grafts (skin, cartilage, bone) and, most importantly, in securing the nasal cartilage properly, and so better to make the appropriate assessment and remedy. This procedural aspect can be especially difficult in revision surgery, and in rhinoplastic alteration of the thick-skinned "ethnic nose" of the person of color. The study, Ethnic Rhinoplasty: a Universal Preoperative Classification System for the Nasal Tip (2009), reports that a nasal-tip classification system, based upon skin thickness, has been proposed to aid the surgeon in determining if an open rhinoplasty or a closed rhinoplasty can best correct the defect or deformity affecting the patient's nose.
Sources: en.wikipedia.org
Calendars – calendars were developed by indigenous Americans throughout North America, Mesoamerica, and South America. They are known to have been in use since 600 BCE. Some calendars were so precise, that by the 5th century BCE, they were only 19 minutes off. Canals – the Aztecs constructed great canals used for transporting food, cargo, and relaying people to the chinampas (floating gardens used for growing food) in their great metropolis of Tenochtitlan. Canoe – many indigenous nations–including the Caribs, Cree, Iroquois, and others–had developed many distinct forms, styles, and types of canoes over the millennia. Cassava – the first cultivation of cassava took place in southern Brazil and eastern Bolivia 8,000-10,000 years ago. Causeway – the Aztec built many giant causeways that connected the mainland to their capital city of Tenochtitlan, located in the heart of the Aztec Empire. The causeways served as arteries used for transporting food, goods, people, captive warriors, and wastes during the heyday of the Aztec Empire in the 14th century to the 16th century. Chaps – these appear to have been first used as a sort of leather armor to protect the legs from injury during guerrilla attacks by east coast native peoples. Some of these peoples ended up migrating to Texas shortly before the Texas Revolution, where it appears that others discovered that wearing chaps over pants reduced chafing on long horseback rides. It came to be later adopted by US, Mexican, and indigenous horse-riding cultures.
===== MeSH D08.811.277.450 – glycoside hydrolases ===== MeSH D08.811.277.450.066 – amylases MeSH D08.811.277.450.066.050 – alpha-amylase MeSH D08.811.277.450.066.100 – beta-amylase MeSH D08.811.277.450.114 – beta-fructofuranosidase MeSH D08.811.277.450.207 – chitinase MeSH D08.811.277.450.283 – dextranase MeSH D08.811.277.450.329 – disaccharidases MeSH D08.811.277.450.329.738 – sucrase MeSH D08.811.277.450.329.738.700 – sucrase-isomaltase complex MeSH D08.811.277.450.329.865 – trehalase MeSH D08.811.277.450.400 – alpha-L-fucosidase MeSH D08.811.277.450.410 – galactosidases MeSH D08.811.277.450.410.050 – alpha-galactosidase MeSH D08.811.277.450.410.100 – beta-galactosidase MeSH D08.811.277.450.410.100.500 – lactase MeSH D08.811.277.450.410.150 – ceramide trihexosidase MeSH D08.811.277.450.410.400 – galactosylceramidase MeSH D08.811.277.450.420 – glucosidases MeSH D08.811.277.450.420.050 – alpha-glucosidases MeSH D08.811.277.450.420.200 – cellulases MeSH D08.811.277.450.420.200.100 – beta-glucosidase MeSH D08.811.277.450.420.200.200 – cellulase MeSH D08.811.277.450.420.200.400 – cellulose 1,4-beta-cellobiosidase MeSH D08.811.277.450.420.200.450 – endo-1,3(4)-beta-glucanase MeSH D08.811.277.450.420.200.500 – glucan 1,3-beta-glucosidase MeSH D08.811.277.450.420.200.550 – glucan 1,4-beta-glucosidase MeSH D08.811.277.450.420.200.600 – glucan endo-1,3-beta-d-glucosidase MeSH D08.811.277.450.420.375 – glucan 1,4-alpha-glucosidase MeSH D08.811.277.450.420.450 – glycogen debranching enzyme system MeSH D08.811.277.450.420.475 – glycosylceramidase MeSH D08.811.277.450.420.475.400 – glucosylceramidase MeSH D08.811.277.450.426 – glucuronidase MeSH D08.811.277.450.483 – hexosaminidases MeSH D08.811.277.450.483.021 – acetylglucosaminidase MeSH D08.811.277.450.483.044 – alpha-N-acetylgalactosaminidase MeSH D08.811.277.450.483.112 – Beta-N-acetylgalactosaminidase MeSH D08.811.277.450.483.180 – Beta-N-acetylhexosaminidase MeSH D08.811.277.450.483.765 – Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase MeSH D08.811.277.450.529 – hyaluronoglucosaminidase MeSH D08.811.277.450.560 – iduronidase MeSH D08.811.277.450.585 – isoamylase MeSH D08.811.277.450.625 – mannosidases MeSH D08.811.277.450.625.500 – alpha-mannosidase MeSH D08.811.277.450.625.750 – beta-mannosidase MeSH D08.811.277.450.642 – muramidase MeSH D08.811.277.450.692 – neuraminidase MeSH D08.811.277.450.737 – n-glycosyl hydrolases MeSH D08.811.277.450.737.099 – dna glycosylases MeSH D08.811.277.450.737.099.500 – DNA-formamidopyrimidine glycosylase MeSH D08.811.277.450.737.099.750 – thymine dna glycosylase MeSH D08.811.277.450.737.400 – nad+ nucleosidase MeSH D08.811.277.450.737.400.060 – adp-ribosyl cyclase MeSH D08.811.277.450.737.400.060.500 – antigens, cd38 MeSH D08.811.277.450.770 – oligo-1,6-glucosidase MeSH D08.811.277.450.770.800 – sucrase-isomaltase complex MeSH D08.811.277.450.800 – polygalacturonase MeSH D08.811.277.450.950 – xylosidases MeSH D08.811.277.450.950.249 – endo-1,4-beta xylanases MeSH D08.811.277.450.950.500 – xylan endo-1,3-beta-xylosidase
=== Scientific cores === The bioinformatics core contributes bioinformatic analysis by collecting and curating complete sequence data sets, generating sequence similarity networks, and classification of superfamily members into subgroups and families for subsequent annotation transfer and evaluation as targets for functional characterization. The protein core develops cloning, expression, and protein purification strategies for the enzymes targeted for study. The structure core fulfills the structural biology component for EFI by providing high resolution structures of targeted enzymes. The computation core performs in silico docking to generate rank-ordered lists of predicted substrates for targeted enzymes using both experimentally determined and/or homology modeled protein structures. The microbiology core examines in vivo functions using genetic techniques and metabolomics to complement in vitro functions determined by the Bridging Projects. The data and dissemination core maintains a public database for experimental data (EFI-DB).
Sources: en.wikipedia.org
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.
Single-receptor agents act predominantly at GLP-1R. Tirzepatide retains activity at GIPR, which is expressed in pancreatic islets, adipose tissue, and the central nervous system. The contribution of each receptor to the overall response is still an area of active study, and the relative weight of GIPR signaling in humans is not fully settled.
The fatty diacid moiety binds serum albumin, which reduces renal filtration of the active peptide. Additional resistance to enzymatic breakdown comes from non-natural residues in the backbone. Together these features produce an apparent half-life of about five days and permit weekly dosing intervals.
It is normally kept frozen, desiccated, and away from light, with brief warming to room temperature before opening to limit condensation. Repeated freeze-thaw cycles are avoided because they stress the peptide. Once in solution, the material is held cold and used promptly.